{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:36:02Z","timestamp":1784896562804,"version":"3.55.0"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"17","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Toward the goal of developing effective treatments for prostate cancers, we examined the effects of cyclin-dependent kinase inhibitors on the survival of prostate cancer cells. We show that roscovitine, R-roscovitine, and CGP74514A (collectively referred to as CKIs) induce the apoptosis of LNCaP and LNCaP-Rf cells, both of which express wild-type p53. Apoptosis required caspase-9 and caspase-3 activity, and cytochrome c accumulated in the cytosol of CKI-treated cells. Amounts of p53 increased substantially in CKI-treated cells, whereas amounts of the endogenous caspase inhibitor XIAP decreased. CKIs did not appreciably induce the apoptosis of LNCaP cells treated with pifithrin-\u03b1, which prevents p53 accumulation, or of prostate cancer cells that lack p53 function (PC3 and DU145). Ectopic expression of p53 in PC3 cells for 44 hours did not reduce XIAP abundance or induce apoptosis. However, p53-expressing PC3 cells readily apoptosed when exposed to CKIs or when depleted of XIAP by RNA interference. These findings show that CKIs induce the mitochondria-mediated apoptosis of prostate cancer cells by a dual mechanism: p53 accumulation and XIAP depletion. They suggest that these events in combination may prove useful in the treatment of advanced prostate cancers.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-0347","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T22:27:13Z","timestamp":1500676033000},"page":"7717-7723","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Accumulation of p53 and Reductions in XIAP Abundance Promote the Apoptosis of Prostate Cancer Cells"],"prefix":"10.1158","volume":"65","author":[{"given":"Subhra","family":"Mohapatra","sequence":"first","affiliation":[{"name":"Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoky","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Pledger","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"2023011120204746300_B1","doi-asserted-by":"crossref","unstructured":"Meijer L, Borgne A, Mulner O, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem\u20081997; 243: 527\u201336.","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x"},{"key":"2023011120204746300_B2","doi-asserted-by":"crossref","unstructured":"McClue SJ, Blake D, Clarke R, et al. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int J Cancer\u20082002; 102: 463\u20138.","DOI":"10.1002\/ijc.10738"},{"key":"2023011120204746300_B3","doi-asserted-by":"crossref","unstructured":"Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J. 2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors. Bioorg Med Chem Lett\u20081999; 9: 91\u20136.","DOI":"10.1016\/S0960-894X(98)00691-X"},{"key":"2023011120204746300_B4","doi-asserted-by":"crossref","unstructured":"David-Pfeuty T. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells. Oncogene\u20081999; 18: 7409\u201322.","DOI":"10.1038\/sj.onc.1203103"},{"key":"2023011120204746300_B5","doi-asserted-by":"crossref","unstructured":"Mihara M, Shintani S, Kiyota A, Matsumura T, Wong DT. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells. Int J Oncol\u20082002; 21: 95\u2013101.","DOI":"10.3892\/ijo.21.1.95"},{"key":"2023011120204746300_B6","doi-asserted-by":"crossref","unstructured":"Wojciechowski J, Horky M, Gueorguieva M, Wesierska-Gadek J. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells. Int J Cancer\u20082002; 106: 486\u201395.","DOI":"10.1002\/ijc.11290"},{"key":"2023011120204746300_B7","doi-asserted-by":"crossref","unstructured":"Dai Y, Dent P, Grant S. Induction of apoptosis in human leukemia cells by the CDK1 inhibitor CGP74514A. Cell Cycle\u20082002; 1: 143\u201352.","DOI":"10.4161\/cc.1.2.116"},{"key":"2023011120204746300_B8","unstructured":"Mohapatra S, Chu B, Wei S, et al. Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2. Cancer Res\u20082003; 63: 8523\u201330."},{"key":"2023011120204746300_B9","doi-asserted-by":"crossref","unstructured":"Lu W, Chen L, Peng Y, Chen J. Activation of p53 by roscovitine-mediated suppression of MDM2 expression. Oncogene\u20082001; 20: 3206\u201316.","DOI":"10.1038\/sj.onc.1204412"},{"key":"2023011120204746300_B10","doi-asserted-by":"crossref","unstructured":"Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem\u20082000; 69: 217\u201345.","DOI":"10.1146\/annurev.biochem.69.1.217"},{"key":"2023011120204746300_B11","doi-asserted-by":"crossref","unstructured":"Vaux DL, Silke J. Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun\u20082003; 304: 499\u2013504.","DOI":"10.1016\/S0006-291X(03)00622-3"},{"key":"2023011120204746300_B12","doi-asserted-by":"crossref","unstructured":"Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J\u20081998; 17: 2215\u201323.","DOI":"10.1093\/emboj\/17.8.2215"},{"key":"2023011120204746300_B13","doi-asserted-by":"crossref","unstructured":"Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol\u20082003; 39: 615\u201347.","DOI":"10.1016\/S0161-5890(02)00252-3"},{"key":"2023011120204746300_B14","doi-asserted-by":"crossref","unstructured":"Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene\u20082003; 22: 9030\u201340.","DOI":"10.1038\/sj.onc.1207116"},{"key":"2023011120204746300_B15","doi-asserted-by":"crossref","unstructured":"Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell\u20081995; 80: 293\u20139.","DOI":"10.1016\/0092-8674(95)90412-3"},{"key":"2023011120204746300_B16","doi-asserted-by":"crossref","unstructured":"Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell\u20082001; 7: 683\u201394.","DOI":"10.1016\/S1097-2765(01)00214-3"},{"key":"2023011120204746300_B17","doi-asserted-by":"crossref","unstructured":"Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science\u20082000; 288: 1053\u20138.","DOI":"10.1126\/science.288.5468.1053"},{"key":"2023011120204746300_B18","doi-asserted-by":"crossref","unstructured":"Murphy ME, Leu JI, George DL. p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle\u20082004; 3: 836\u20139.","DOI":"10.4161\/cc.3.7.956"},{"key":"2023011120204746300_B19","doi-asserted-by":"crossref","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science\u20081991; 253: 49\u201353.","DOI":"10.1126\/science.1905840"},{"key":"2023011120204746300_B20","doi-asserted-by":"crossref","unstructured":"Leers MP, Kolgen W, Bjorklund V, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol\u20081999; 187: 567\u201372.","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J"},{"key":"2023011120204746300_B21","doi-asserted-by":"crossref","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science\u20082002; 296: 1655\u20137.","DOI":"10.1126\/science.296.5573.1655"},{"key":"2023011120204746300_B22","unstructured":"Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3\u2032-kinase and Akt\/protein kinase B. Cancer Res\u20081999; 59: 1449\u201353."},{"key":"2023011120204746300_B23","unstructured":"Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res\u20082002; 62: 1008\u201313."},{"key":"2023011120204746300_B24","doi-asserted-by":"crossref","unstructured":"Blaydes JP, Craig AL, Wallace M, et al. Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways. Oncogene\u20082000; 19: 3829\u201339.","DOI":"10.1038\/sj.onc.1203773"},{"key":"2023011120204746300_B25","doi-asserted-by":"crossref","unstructured":"Kim EH, Kim SU, Shin DY, Choi KS. Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP. Oncogene\u20082004; 23: 446\u201356.","DOI":"10.1038\/sj.onc.1207025"},{"key":"2023011120204746300_B26","doi-asserted-by":"crossref","unstructured":"el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell\u20081993; 75: 817\u201325.","DOI":"10.1016\/0092-8674(93)90500-P"},{"key":"2023011120204746300_B27","doi-asserted-by":"crossref","unstructured":"Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science\u20081999; 285: 1733\u20137.","DOI":"10.1126\/science.285.5434.1733"},{"key":"2023011120204746300_B28","doi-asserted-by":"crossref","unstructured":"Schneider-Stock R, Diab-Asseff M, Rohrbeck A, et al. 5-AZA-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther\u20082005; 312: 525\u201336.","DOI":"10.1124\/jpet.104.074195"},{"key":"2023011120204746300_B29","doi-asserted-by":"crossref","unstructured":"Lorenzo E, Ruiz-Ruiz C, Quesada AJ, et al. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J Biol Chem\u20082002; 277: 10883\u201392.","DOI":"10.1074\/jbc.M107442200"},{"key":"2023011120204746300_B30","doi-asserted-by":"crossref","unstructured":"Nomura T, Mimata H, Takeuchi Y, Yamamoto H, Miyamoto E, Nomura Y. The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells. Urol Res\u20082003; 31: 37\u201344.","DOI":"10.1007\/s00240-003-0300-y"},{"key":"2023011120204746300_B31","doi-asserted-by":"crossref","unstructured":"Nomura T, Mimata H, Yamasaki M, Nomura Y. Cisplatin inhibits the expression of X-linked inhibitor of apoptosis protein in human LNCaP cells. Urol Oncol\u20082004; 22: 453\u201360.","DOI":"10.1016\/j.urolonc.2004.04.035"},{"key":"2023011120204746300_B32","unstructured":"Asselin E, Mills GB, Tsang BK. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res\u20082001; 61: 1862\u20138."},{"key":"2023011120204746300_B33","doi-asserted-by":"crossref","unstructured":"Li J, Feng Q, Kim JM, et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology\u20082001; 142: 370\u201380.","DOI":"10.1210\/endo.142.1.7897"},{"key":"2023011120204746300_B34","doi-asserted-by":"crossref","unstructured":"Duckett CS, Li F, Wang Y, Tomaselli KJ, Thompson CB, Armstrong RC. Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c. Mol Cell Biol\u20081998; 18: 608\u201315.","DOI":"10.1128\/MCB.18.1.608"},{"key":"2023011120204746300_B35","doi-asserted-by":"crossref","unstructured":"Holcik M, Yeh C, Korneluk RG, Chow T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene\u20082000; 19: 4174\u20137.","DOI":"10.1038\/sj.onc.1203765"},{"key":"2023011120204746300_B36","doi-asserted-by":"crossref","unstructured":"Hara I, Miyake H, Hara S, Arakawa S, Kamidono S. Differential involvement of the Fas receptor\/ligand system in p53-dependent apoptosis in human prostate cancer cells. Prostate\u20082000; 45: 341\u20139.","DOI":"10.1002\/1097-0045(20001201)45:4<341::AID-PROS9>3.0.CO;2-M"},{"key":"2023011120204746300_B37","doi-asserted-by":"crossref","unstructured":"Srivastava S, Katayose D, Tong YA, et al. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation. Urology\u20081995; 46: 843\u20138.","DOI":"10.1016\/S0090-4295(99)80355-0"},{"key":"2023011120204746300_B38","unstructured":"Roy I, Holle L, Song W, Holle E, Wagner T, Yu X. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res\u20082002; 22: 3185\u20139."},{"key":"2023011120204746300_B39","unstructured":"Davies MA, Koul D, Dhesi H, et al. Regulation of Akt\/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC\/PTEN. Cancer Res\u20081999; 59: 2551\u20136."},{"key":"2023011120204746300_B40","doi-asserted-by":"crossref","unstructured":"Schumacher G, Bruckheimer EM, Beham AW, et al. Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells. Int J Cancer\u20082001; 91: 159\u201366.","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1026>3.3.CO;2-E"},{"key":"2023011120204746300_B41","doi-asserted-by":"crossref","unstructured":"Colletier PJ, Ashoori F, Cowen D, et al. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation. Int J Radiat Oncol Biol Phys\u20082000; 48: 1507\u201312.","DOI":"10.1016\/S0360-3016(00)01409-7"},{"key":"2023011120204746300_B42","doi-asserted-by":"crossref","unstructured":"Amantana A, London CA, Iversen PL, Devi GR. X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther\u20082004; 3: 699\u2013707.","DOI":"10.1158\/1535-7163.699.3.6"},{"key":"2023011120204746300_B43","unstructured":"Carson JP, Behnam M, Sutton JN, et al. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Res\u20082002; 62: 18\u201323."},{"key":"2023011120204746300_B44","doi-asserted-by":"crossref","unstructured":"Dahmus ME. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J Biol Chem\u20081996; 271: 19009\u201312.","DOI":"10.1074\/jbc.271.32.19009"},{"key":"2023011120204746300_B45","unstructured":"Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res\u20082003; 1: 1001\u20138."},{"key":"2023011120204746300_B46","unstructured":"Price BD, Hughes-Davies L, Park SJ. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene\u20081995; 11: 73\u201380."},{"key":"2023011120204746300_B47","doi-asserted-by":"crossref","unstructured":"Wang Y, Prives C. Increased and altered DNA binding of human p53 by S and G2\/M but not G1 cyclin-dependent kinases. Nature\u20081995; 376: 88\u201391.","DOI":"10.1038\/376088a0"},{"key":"2023011120204746300_B48","doi-asserted-by":"crossref","unstructured":"Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci U S A\u20081990; 87: 4766\u201370.","DOI":"10.1073\/pnas.87.12.4766"},{"key":"2023011120204746300_B49","doi-asserted-by":"crossref","unstructured":"Sakaguchi K, Sakamoto H, Xie D, et al. Effect of phosphorylation on tetramerization of the tumor suppressor protein p53. J Protein Chem\u20081997; 16: 553\u20136.","DOI":"10.1023\/A:1026334116189"},{"key":"2023011120204746300_B50","doi-asserted-by":"crossref","unstructured":"Ko LJ, Shieh SY, Chen X, et al. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol\u20081997; 17: 7220\u20139.","DOI":"10.1128\/MCB.17.12.7220"},{"key":"2023011120204746300_B51","doi-asserted-by":"crossref","unstructured":"Lu H, Fisher RP, Bailey P, Levine AJ. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol Cell Biol\u20081997; 17: 5923\u201334.","DOI":"10.1128\/MCB.17.10.5923"},{"key":"2023011120204746300_B52","doi-asserted-by":"crossref","unstructured":"Siddiqui E, Mumtaz FH, Gelister J. Understanding prostate cancer. J R Soc Health\u20082004; 124: 219\u201321.","DOI":"10.1177\/146642400412400518"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/17\/7717\/2536817\/7717-7723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/17\/7717\/2536817\/7717-7723.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T21:49:49Z","timestamp":1673473789000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/17\/7717\/518600\/Accumulation-of-p53-and-Reductions-in-XIAP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":52,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-0347","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}